<http://webisa.webdatacommons.org/prov/157362581>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/345839026> .
<http://webisa.webdatacommons.org/prov/308325876>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/345839026> .
<http://webisa.webdatacommons.org/345839026>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/345839026>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/160651529>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/345839026> .
<http://webisa.webdatacommons.org/345839026>	<http://www.w3.org/ns/prov#value>	"It is a further object of the present invention to provide a method and associated assay system for screening substances such as drugs, agents and the like, potentially effective in either mimicking the activity or combating the adverse effects of the GPCR binding to ligands in mammals." .